Ligand validation:3IFX

MTN: S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate

MTN is a Ligand Of Interest in 3IFX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3IFX_MTN_D_248	19%	5%	0.271	0.912	1.71	3.68	2	7	6	0	75%	0.375
3IFX_MTN_B_248	5%	8%	0.398	0.846	2.13	2.76	2	4	4	0	75%	0.375
3STZ_MTN_C_201	0%	2%	0.721	0.827	3.66	3.59	4	7	0	0	75%	0.2063
5JDT_MTN_A_201	92%	4%	0.05	0.984	1.99	3.77	3	5	1	0	75%	0.285
2XIU_MTN_B_1055	76%	8%	0.083	0.964	2.05	2.82	2	4	2	0	75%	0.63
5BMH_MTN_A_101	76%	26%	0.084	0.965	1.78	1.39	2	2	0	0	75%	0.375
2Q9E_MTN_A_844	74%	12%	0.105	0.981	2.86	1.4	7	1	0	0	75%	0.75
2XGA_MTN_B_1019	65%	26%	0.089	0.934	1.29	1.82	1	2	2	0	75%	0.75

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.